Table 1.
Patient characteristics and outcomes.
| Characteristic | Lipiodol lymphangiography n = 18 |
Lipiodol lymphangiography combined embolization n = 26 |
p-value |
|---|---|---|---|
| Age (year) | 52.8 ± 12.4 | 51.8 ± 15.9 | 0.875 |
| Gender (male) | 6 (33.3%) | 20 (76.9%) | – |
| Indication for the procedure | – | ||
| Chylothorax | 6 (33.3%) | 6 (23.1%) | |
| Chylous ascites | 10 (55.6%) | 16 (61.5%) | |
| Chyluria | 0 | 2 (7.7%) | |
| other | 2 (11.1%) | 2 (7.7%) | |
| Duration of symptom (month) | 2.6 ± 2.4 | 1.3 ± 0.6 | 0.155 |
| Previous Treatment | – | ||
| Surgery | 6 (33.3%) | 16 (61.5%) | |
| No obvious causes | 12 (66.7%) | 10 (38.5%) | |
| Number of lymphangiography | 1.11 | 1.23 | – |
| Dose of Lipiodol (mL) | 21.4 ± 5.3 | 23.4 ± 7.2 | 0.501 |
| Liquid embolic agent (mL) | 0 | 3.1 ± 1.5 | – |
| Procedural duration (min) | 137.5 ± 31.2 | 128.1 ± 54.7 | 0.473 |
| Technique success | 100% | 100% | – |
| Clinical success | 10 (55.6%) | 22 (84.6%) | 0.075 |
| Clinical resolution time (day) | 13.6 ± 5.7 | 6.2 ± 6.5 | 0.004 |